应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
06127 昭衍新药
午间休市 02-02 12:05:00
21.440
-2.880
-11.84%
最高
24.000
最低
21.300
成交量
462.29万
今开
23.700
昨收
24.320
日振幅
11.10%
总市值
160.59亿
流通市值
25.51亿
总股本
7.49亿
成交额
1.03亿
换手率
3.88%
流通股本
1.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
每周股票复盘：昭衍新药（603127）股东周志文减持1497.9万股
证券之星 · 02-01 01:49
每周股票复盘：昭衍新药（603127）股东周志文减持1497.9万股
每日卖空追踪 | 昭衍新药 01月30日卖空量成交19.95万股，卖空比例为4.31%
市场透视 · 01-30 16:30
每日卖空追踪 | 昭衍新药 01月30日卖空量成交19.95万股，卖空比例为4.31%
AI重塑医药生产力，为何超六成医药企业拥抱钉钉？
上观新闻 · 01-30
AI重塑医药生产力，为何超六成医药企业拥抱钉钉？
昭衍新药：周志文已减持1497.90万股
南方财经网 · 01-29
昭衍新药：周志文已减持1497.90万股
每日卖空追踪 | 昭衍新药 01月27日卖空量成交26.53万股，卖空比例为6.1%
市场透视 · 01-27
每日卖空追踪 | 昭衍新药 01月27日卖空量成交26.53万股，卖空比例为6.1%
昭衍新药盘中异动 急速下挫5.13%报24.420港元
市场透视 · 01-27
昭衍新药盘中异动 急速下挫5.13%报24.420港元
实验猴涨价推动昭衍新药业绩反转，预计2025年扣非净利同比增长超9倍
每日经济新闻 · 01-26
实验猴涨价推动昭衍新药业绩反转，预计2025年扣非净利同比增长超9倍
每日卖空追踪 | 昭衍新药 01月26日卖空量成交2.65万股，卖空比例为0.78%
市场透视 · 01-26
每日卖空追踪 | 昭衍新药 01月26日卖空量成交2.65万股，卖空比例为0.78%
每周股票复盘：昭衍新药（603127）股东周志文减持1010.37万股
证券之星 · 01-25
每周股票复盘：昭衍新药（603127）股东周志文减持1010.37万股
医药生物行业：基金持仓重回底部 建议持续加配医药底部资产
中泰证券 · 01-25
医药生物行业：基金持仓重回底部 建议持续加配医药底部资产
1月23日昭衍新药现2笔折价12.81%的大宗交易 合计成交2.13亿元
证券之星 · 01-23
1月23日昭衍新药现2笔折价12.81%的大宗交易 合计成交2.13亿元
药明康德、康龙化成等CRO头部企业披露2025年业绩，多家净利润大增！
制药网 · 01-23
药明康德、康龙化成等CRO头部企业披露2025年业绩，多家净利润大增！
医药生物行业双周报：部分地区取消医院用药数量限制
东莞证券 · 01-23
医药生物行业双周报：部分地区取消医院用药数量限制
猴价上涨，CXO公司赚翻了
医药投资部落 · 01-22
猴价上涨，CXO公司赚翻了
去年四季度买回昭衍新药、中国东航，中欧基金葛兰：一季度医药板块有望延续结构性行情
澎湃新闻 · 01-22
去年四季度买回昭衍新药、中国东航，中欧基金葛兰：一季度医药板块有望延续结构性行情
每日卖空追踪 | 昭衍新药 01月22日卖空量成交8000股，卖空比例为0.35%
市场透视 · 01-22
每日卖空追踪 | 昭衍新药 01月22日卖空量成交8000股，卖空比例为0.35%
昭衍新药：增减持计划可实施日期提醒
大智慧idata · 01-22
昭衍新药：增减持计划可实施日期提醒
富贵猴中求？实验猴价格涨至15万元一只，昭衍新药净利润预增超214%
时代财经 · 01-21
富贵猴中求？实验猴价格涨至15万元一只，昭衍新药净利润预增超214%
徐慕浩2025年四季度表现，泰信蓝筹精选混合基金季度涨幅3.31%
证券之星 · 01-21
徐慕浩2025年四季度表现，泰信蓝筹精选混合基金季度涨幅3.31%
港股早知道 | 赤峰黄金预计2025年净利润同比增约70%-81%！创维集团拟私有化退市并分拆光伏业务上市
智通财经 · 01-21
港股早知道 | 赤峰黄金预计2025年净利润同比增约70%-81%！创维集团拟私有化退市并分拆光伏业务上市
加载更多
公司概况
公司名称：
昭衍新药
所属市场：
SEHK
上市日期：
--
主营业务：
北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。
发行价格：
--
{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":21.44,"timestamp":1770005100006,"preClose":24.32,"halted":0,"volume":4622903,"delay":0,"changeRate":-0.1184210526315789,"floatShares":118995206,"shares":749000000,"eps":0.1,"marketStatus":"午间休市","change":-2.88,"latestTime":"02-02 12:05:00","open":23.7,"high":24,"low":21.3,"amount":103101019,"amplitude":0.11102,"askPrice":21.46,"askSize":4300,"bidPrice":21.42,"bidSize":200,"shortable":3,"etf":0,"ttmEps":0.329,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770008400000},"marketStatusCode":3,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":24.32,"dividendRate":0.00157,"openAndCloseTimeList":[[1769995800000,1770004800000],[1770008400000,1770019200000]],"volumeRatio":2.690853,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":36.69,"timestamp":1770002998000,"preClose":38.01,"halted":0,"volume":8556900,"delay":0,"premium":"-47.98"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2608727350","title":"每周股票复盘：昭衍新药（603127）股东周志文减持1497.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608727350","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608727350?lang=zh_cn&edition=full","pubTime":"2026-02-01 01:49","pubTimestamp":1769881750,"startTime":"0","endTime":"0","summary":"来自股本股东变化：股东周志文于2026年1月24日至28日合计减持487.53万股，占总股本0.6506%。交易信息汇总1月28日昭衍新药发生2笔大宗交易，成交金额8830.64万元。股本股东变化股东周志文于2026年1月24日至2026年1月28日间合计减持487.53万股，占公司目前总股本的0.6506%，变动期间该股股价下跌7.65%，截止1月28日收盘报37.93元。周志文决定提前终止减持计划，实际减持情况与披露计划一致，未违反相关承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0216","BK1141","06127","603127"],"gpt_icon":0},{"id":"2607026278","title":"每日卖空追踪 | 昭衍新药 01月30日卖空量成交19.95万股，卖空比例为4.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607026278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607026278?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:30","pubTimestamp":1769761837,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间01月30日，涨4.38%，卖空量成交19.95万股，较上一交易日减少23.12%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164119a6bf4eaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164119a6bf4eaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","06127"],"gpt_icon":0},{"id":"2607025472","title":"AI重塑医药生产力，为何超六成医药企业拥抱钉钉？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607025472","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607025472?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:43","pubTimestamp":1769737380,"startTime":"0","endTime":"0","summary":"以“AI重塑医药生产力”为主题的2026医药钉峰会日前在沪召开，共探人工智能技术如何驱动赋能医药行业。AI自动完成数据抓取、分析与预警，让人人皆可成为开发者，大幅提升了业务响应的敏捷性。此外，AI正成为药企全球化协同的基石。AI不再是遥远的技术概念，而是已经成为医药行业提质、增效、创新的核心驱动要素。随着AI技术产品持续完善、行业生态日益繁荣，一场以人工智能为核心的医药生产力革命，正从蓝图加速照进现实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130095032a466dcda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130095032a466dcda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0819121731.USD","LU0708995153.HKD","LU0235996351.USD","BK1588","LU2778985437.USD","LU0823041008.USD","LU0823413660.USD","LU1051768304.USD","LU0264606111.USD","LU0320764599.SGD","LU0441854154.USD","BK1521","LU0543330566.HKD","LU0873338254.USD","LU0611395673.USD","LU0979878070.USD","LU0675040207.SGD","LU0516423174.USD","LU0127658192.USD","LU1719994722.HKD","LU0054237671.USD","SG9999004220.SGD","LU1720050803.USD","LU0329678337.USD","LU2328871848.SGD","LU0856984785.SGD","LU1048484197.HKD","LU0455707207.USD","SG9999000459.SGD","LU0577902454.USD","LU0784639295.USD","BK1615","LU2242644610.SGD","LU1831875114.USD","LU0348735423.USD","BK1517","LU0762540952.USD","02157","LU0417516738.SGD","LU0823039010.USD","LU2399975544.HKD","LU0577902538.SGD","LU0588545730.USD","LU3063872942.SGD","LU0828237510.HKD","LU1642822792.SGD","LU0143863198.USD","LU0181495838.USD","LU1880383440.USD","BK1608","LU0130518102.USD","BK1583","LU0054450605.USD","BK1610","LU0359201885.HKD","01276","LU0163747925.USD","LU0541502299.USD","LU0314109678.HKD","LU1282651048.USD","LU0449515922.USD","LU0865486749.SGD","LU0868486357.SGD","IE00B3M56506.USD","LU1880398471.USD","LU0831103253.SGD","LU1504937902.USD","LU1044876610.USD","LU0345776255.USD","LU1242518931.SGD","LU1769817179.HKD","LU0011963245.USD","LU0320764755.SGD","LU1282649810.SGD","LU0823397103.USD","LU2125910500.SGD","LU0327786744.USD","SG9999001093.SGD","LU0348788117.USD","LU0348827113.USD","LU1969619763.USD","LU1224444064.USD","LU2045819591.USD","LU0594300419.USD","LU1196710864.SGD","LU1956131251.USD","LU0287142896.SGD","LU0214875030.USD","89988","LU0251144936.SGD","LU1044875133.USD","LU2097828714.EUR","LU1188198961.HKD","LU0821914370.USD","LU0708995583.HKD","IE00B0JY6N72.USD","LU1316542783.SGD","LU1808992512.USD","LU0469268626.HKD","LU0106959298.USD","LU0823413587.USD","LU0164872284.USD","SG9999000327.SGD","LU0320764243.SGD","LU0588545904.SGD","06127","IE0032431581.USD","IE00B0169N27.USD","LU0890818403.SGD","LU0862451837.USD","LU2152927971.USD","LU0348783662.USD","LU0607220059.USD","BK1591","LU0164865239.USD","BK1501","LU0502904849.HKD","LU0572940350.SGD","LU1044874839.SGD","LU1481107354.HKD","LU0128522744.USD","LU1048596156.SGD","SGXZ90724238.SGD","LU1770036033.HKD","LU0499858602.USD","LU0210526637.USD","LU0128522157.USD","LU0516422366.SGD","601607","LU0886674414.USD","LU0029874905.USD","LU0823038988.USD","LU0417516571.SGD","IE0003895053.USD","LU0048580855.USD","LU1993786604.SGD","LU1282649141.HKD","LU0456846285.SGD","LU1023057109.AUD","09988","LU0871576103.HKD","LU1048588211.SGD","LU2097828631.EUR","LU0608807946.USD","LU1328615791.USD","LU0828237940.HKD","LU0051755006.USD","LU1794554557.SGD","LU1655091459.SGD","SG9999006514.SGD","LU0254981946.USD","LU0516422952.EUR","LU0348805143.USD","BK1142","BABA","LU0315178854.USD","LU1720051108.HKD","LU0449509016.USD","LU0737861699.HKD","LU0531971595.HKD","02607","LU1439103000.SGD","LU0831093199.SGD","LU0456827905.SGD","IE00B5MMRT66.SGD","LU0672654166.SGD","LU0516423091.SGD","LU0737861772.HKD","LU1981816686.USD","LU0231483743.USD","LU1115378108.SGD","BK1586","LU0307460666.USD","IE00B543WZ88.USD","LU1303224171.USD","LU2293587155.HKD","LU0577902611.USD","LU2097828474.EUR","SG9999002828.SGD","LU0540923850.HKD","LU0651946864.USD","BK1589","SG9999002463.SGD","LU0132412106.USD","LU1323998911.USD","IE00BZ08YR35.GBP","LU0823040885.USD","LU0762542818.HKD","BK1249","LU2449936058.SGD","000538","LU1051769294.HKD","LU1807302812.USD","LU1960683339.HKD","HK0000320223.HKD","LU0348783233.USD","LU0819123356.HKD","SG9999001689.USD","IE00BPRC5H50.USD","LU0164880469.USD","LU0048597586.USD","LU1211504680.USD","LU0700851271.USD","LU0169518387.USD","LU0359201612.USD","LU0608807433.USD","LU1201861165.SGD","LU0516422440.USD","SG9999001051.SGD","LU0173614495.USD","LU0149721374.USD","LU0499858438.USD","LU0293314216.USD","LU0463099449.HKD","LU2097829019.USD","BK1161","LU2087589342.USD","LU0593848301.USD","LU2476274720.SGD","LU1880398554.USD","LU0359202008.SGD","IE00BMPRXN33.USD","SG9999006597.SGD","HK0000320264.USD","LU0648948544.HKD","LU0117844026.USD","LU0096374516.USD","LU1548497426.USD","BK1618","LU1720051017.SGD","LU0029875118.USD","BK1515","LU0589944569.HKD","LU1961090484.USD","LU0228659784.USD","LU1282651121.HKD","LU2257852520.SGD","IE0034224299.USD","LU0348825331.USD","LU0577902371.SGD","LU0117841782.USD","LU0630378429.USD","LU0049853897.USD","LU0823397285.USD","LU0197773160.USD","LU0384037296.USD","LU1515016050.SGD","SG9999001226.SGD","IE00BZ08YT58.USD","LU0196878994.USD","LU0143863784.USD","LU0345775950.USD","LU0228367735.SGD","LU0052750758.USD","SG9999002562.SGD","LU0084288322.USD","LU1242518857.USD","LU0165289439.USD","LU0197773673.USD","01801","600276","LU0634319403.HKD","LU1366334578.USD","LU0244354667.USD","LU0259732245.USD","IE00BZ08YS42.EUR","IE00BMPRXR70.SGD","LU0149534421.HKD","LU0328353924.USD","LU0642271901.SGD","BK1574","LU0261950983.USD","BK1584","LU1224709979.USD","HK0000306701.USD","SHPMY","LU0588545490.SGD","LU0326950275.SGD","LU0640798160.USD","LU0762541174.USD","LU1770034418.SGD","HBBD.SI","LU0791591158.USD","LU0488056044.USD","LU0047713382.USD","LU2488822045.USD","SG9999014674.SGD","LU0862451753.SGD","LU0543330483.HKD","BK1575","LU0651947912.USD","LU0791590937.USD","LU0588546209.SGD","LU0210527791.USD","LU0211977185.USD","LU0048388663.USD","LU0431992006.USD","LU1568876335.HKD","SG9999001903.USD","LU0823426308.USD","LU0630378692.HKD","LU0261947096.USD","LU1880383366.USD","LU0561508036.HKD","LU0140636845.USD","LU1251922891.USD","LU1769817096.USD","LU1810669033.SGD","LU0417516902.SGD","LU0039217434.USD","LU0823426480.USD","LU0370786039.SGD","LU0061477393.USD","LU0898667661.SGD","LU2125910849.SGD","LU0531970944.HKD","LU0594300179.USD","LU0329678170.USD","LU1366334651.USD","LU0348784397.USD","LU0572939691.SGD","HK0000306685.HKD","LU1868837565.USD","LU2097828805.USD","LU2039709279.SGD","LU2097828557.USD","LU0572944931.SGD","LU1328277881.USD","LU1568876251.USD","HK0000165453.HKD","LU1688375341.USD","LU0106259558.USD","LU0541501648.USD","LU0229945570.USD","LU1282649067.USD","LU2357305700.SGD","LU0605514214.HKD","603127","IE0008368304.USD","LU0072462343.USD","LU0130103400.USD","ALBmain","LU0106252389.USD","LU0043850808.USD","LU2476274308.USD","LU1813983027.USD","LU1868838027.USD","LU0650527681.SGD","BK1502","LU0315179316.USD","LU0477156797.USD","LU0396098781.USD","LU0577902298.EUR","LU0648000940.SGD"],"gpt_icon":1},{"id":"2607806707","title":"昭衍新药：周志文已减持1497.90万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607806707","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607806707?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:19","pubTimestamp":1769678358,"startTime":"0","endTime":"0","summary":"南财智讯1月29日电，昭衍新药公告，公司实际控制人之一周志文于2026年1月22日至1月28日通过集中竞价及大宗交易方式合计减持公司A股股份14,979,000股，占公司当前总股本的1.99894%，减持计划已提前终止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601293635326997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","BK0216","BK1576","603127","BK1141"],"gpt_icon":0},{"id":"2606756983","title":"每日卖空追踪 | 昭衍新药 01月27日卖空量成交26.53万股，卖空比例为6.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606756983","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606756983?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502639,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间01月27日，跌6.92%，卖空量成交26.53万股，较上一交易日增加622.89%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164223a45b4045&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164223a45b4045&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1141","BK1576"],"gpt_icon":0},{"id":"2606756601","title":"昭衍新药盘中异动 急速下挫5.13%报24.420港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606756601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606756601?lang=zh_cn&edition=full","pubTime":"2026-01-27 09:43","pubTimestamp":1769478236,"startTime":"0","endTime":"0","summary":"2026年01月27日早盘09时43分，昭衍新药股票出现波动，股价快速下跌5.13%。截至发稿，该股报24.420港元/股，成交量50.14万股，换手率0.42%，振幅5.67%。资金方面，该股资金流入354.052万港元，流出716.023万港元。昭衍新药股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，银诺医药-B、维升药业-B、三叶草生物-B涨幅较大，振幅较大的相关个股有银诺医药-B、中生北控生物科技、MIRXES-B，振幅分别为42.46%、15.91%、12.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012709435797a3807e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012709435797a3807e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2606215319","title":"实验猴涨价推动昭衍新药业绩反转，预计2025年扣非净利同比增长超9倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2606215319","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606215319?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:23","pubTimestamp":1769419411,"startTime":"0","endTime":"0","summary":"1月21日，昭衍新药发布了2025年度业绩预告。公司预计实现营业收入约15.73亿元到17.38亿元，较2024年减少约13.9%到22.1%；实现净利润约2.33亿元到3.49亿元，较2024年增加约214%到371%；实现扣非净利润2.46亿元到3.70亿元，较2024年增加约945.2%到1467.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601263630730329.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601263630730329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","BK0216","BK1141","BK1576","603127"],"gpt_icon":0},{"id":"2606225958","title":"每日卖空追踪 | 昭衍新药 01月26日卖空量成交2.65万股，卖空比例为0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606225958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606225958?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416237,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间01月26日，涨0.31%，卖空量成交2.65万股，较上一交易日减少57.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164139a456ca0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164139a456ca0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","06127","BK1576"],"gpt_icon":0},{"id":"2606234770","title":"每周股票复盘：昭衍新药（603127）股东周志文减持1010.37万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606234770","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606234770?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:09","pubTimestamp":1769278150,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，昭衍新药报收于41.07元，较上周的42.03元下跌2.28%。交易信息汇总1月23日昭衍新药发生2笔大宗交易，合计成交2.13亿元，折价12.81%。股本股东变化股东增减持1月23日，昭衍新药公告股东周志文于2026年1月22日至23日合计减持1010.37万股，占公司总股本1.3483%。北京昭衍新药研究中心股份有限公司于2026年1月23日收到实际控制人周志文减持股份通知。本次权益变动后，周志文及冯宇霞合计持股比例由32.27%降至30.93%，触及1%权益变动刻度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1141","BK1576","06127","603127"],"gpt_icon":0},{"id":"2606706257","title":"医药生物行业：基金持仓重回底部 建议持续加配医药底部资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2606706257","media":"中泰证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606706257?lang=zh_cn&edition=full","pubTime":"2026-01-25 00:00","pubTimestamp":1769270400,"startTime":"0","endTime":"0","summary":"本周医药商业受商务部等9 部门联合印发关于促进药品零售行业高质量发展的意见表现强劲，前期涨幅较大的个股有所回调，医药板块整体表现分化。基金持仓重回底部，建议持续加配医药底部资产。扣除医药基金后医药板块低配2.28%，配置占比较2025Q3 下降0.89pp。本周沪深300 下跌0.62%，医药生物下跌0.39%，处于31 个一级子行业第27 位，本周医药商业、中药、医疗器械、生物制品分别上涨4.26%、0.89%、0.30%、0.07%，化学制药、医疗服务分别下跌1.11%、2.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260125211211a453ef97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260125211211a453ef97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","09939","06127","BK1574","BK1161","01801","BK1515"],"gpt_icon":0},{"id":"2605757184","title":"1月23日昭衍新药现2笔折价12.81%的大宗交易 合计成交2.13亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605757184","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605757184?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:49","pubTimestamp":1769161772,"startTime":"0","endTime":"0","summary":"证券之星消息，1月23日昭衍新药发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交5.95万手，折价成交2笔。该股近期无解禁股上市。截至2026年1月23日收盘，昭衍新药报收于41.07元，上涨3.24%，换手率3.33%，成交量20.98万手，成交额8.67亿元。该股近半年内有股东持股变动，合计净减持226.49万股，股东增减持明细如下表：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为40.13。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300029915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","06127","603127","BK1141","BK1576"],"gpt_icon":0},{"id":"2605381424","title":"药明康德、康龙化成等CRO头部企业披露2025年业绩，多家净利润大增！","url":"https://stock-news.laohu8.com/highlight/detail?id=2605381424","media":"制药网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605381424?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:48","pubTimestamp":1769132901,"startTime":"0","endTime":"0","summary":"近期，国内多家头部CRO企业已相继已发布2025年度业绩预告，包括药明康德、康龙化成、昭衍新药、凯莱英等。从整体来看，多家CRO企业业绩/净利润实现大增。药明康德1月12日，药明康德发布2025年度业绩预增公告。公司预计2025年全年营业收入约454.6亿元，同比增长约15.8% ；预计经调整Non-IFRS归母净利润约149.6亿元，同比增长约41.3%；预计扣非归母净利润约132.4亿元，同比增长约32.6% ；预计归母净利润约191.5亿元，同比增长约102.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123095829a6a2b915&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123095829a6a2b915&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","03759","06127"],"gpt_icon":0},{"id":"2605424382","title":"医药生物行业双周报：部分地区取消医院用药数量限制","url":"https://stock-news.laohu8.com/highlight/detail?id=2605424382","media":"东莞证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605424382?lang=zh_cn&edition=full","pubTime":"2026-01-23 00:00","pubTimestamp":1769097600,"startTime":"0","endTime":"0","summary":"投资要点：SW医药生物行业跑输同期沪深300指数。SW医药生物行业三级细分板块中，多数细分板块均录得正收益，其中线下药店和原料药板块涨幅居前，分别上涨3.14%和2.34%，医药流通和化学制剂板块跌幅居前，分别下跌3.26%和2.87%。近日，河北省医保局在关于执行《国家基本医疗保险、生育保险和工伤保险药品目录》以及《商业健康保险创新药品目录》有关问题的通知中明确，医保部门和卫健部门对定点医疗机构配备药品均无药品数量限制规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123135159a44cf184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123135159a44cf184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","BK1576","BK1141","LU0320764599.SGD","LU0708995583.HKD","LU2125910500.SGD","LU2045819591.USD","02359","06127","LU1046422090.SGD","LU2242644610.SGD","03347","BK1583"],"gpt_icon":0},{"id":"2605443287","title":"猴价上涨，CXO公司赚翻了","url":"https://stock-news.laohu8.com/highlight/detail?id=2605443287","media":"医药投资部落","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605443287?lang=zh_cn&edition=full","pubTime":"2026-01-22 21:35","pubTimestamp":1769088912,"startTime":"0","endTime":"0","summary":"昭衍新药表示，本报告期内，生物资产市场价格上涨叠加自身自然生长增值，双重因素驱动其公允价值正向变动，为公司业绩做出积极贡献。食蟹猴是实验用猴中用量最大的品种，占比接近70%。2023年及2024年，因实验猴价格下跌，昭衍生物生物资产公允价值变动带来的净损失分别为2.67亿元和1.14亿元。而2025年的价格反弹，则一举扭转了此前两年的减值局面，成为利润激增的主因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122214934953debbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122214934953debbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2605491486","title":"去年四季度买回昭衍新药、中国东航，中欧基金葛兰：一季度医药板块有望延续结构性行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2605491486","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605491486?lang=zh_cn&edition=full","pubTime":"2026-01-22 21:14","pubTimestamp":1769087660,"startTime":"0","endTime":"0","summary":"2025年末，中欧基金投资总监葛兰在管基金总规模缩水至“300亿元”梯队。1月22日，据最新披露的2025年四季报，葛兰旗下在管基金总规模由去年三季度末的435.44亿元降至去年四季度末的353.89亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601223627662712.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601223627662712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0010","BK0164","09939","BK0020","BK1161","BK0183","BK0028","BK1515","BK0188","BK0196","BK1141","06127","BK0280","159938","BK0216","BK0012","BK1576","BK0006","BK0053","603127","600115","BK1574"],"gpt_icon":0},{"id":"2605434754","title":"每日卖空追踪 | 昭衍新药 01月22日卖空量成交8000股，卖空比例为0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605434754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605434754?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:30","pubTimestamp":1769070637,"startTime":"0","endTime":"0","summary":"昭衍新药北京时间01月22日，跌2.62%，卖空量成交8000股，较上一交易日减少88.25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163828a4491e60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163828a4491e60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","06127"],"gpt_icon":0},{"id":"2605432804","title":"昭衍新药：增减持计划可实施日期提醒","url":"https://stock-news.laohu8.com/highlight/detail?id=2605432804","media":"大智慧idata","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605432804?lang=zh_cn&edition=full","pubTime":"2026-01-22 08:00","pubTimestamp":1769040010,"startTime":"0","endTime":"0","summary":"公司实际控制人周志文计划自2026年01月22日起至2026年04月21日，拟减持不超过1498.00万股，占总股本比例2.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122081920a69e058c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122081920a69e058c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141"],"gpt_icon":0},{"id":"2605103044","title":"富贵猴中求？实验猴价格涨至15万元一只，昭衍新药净利润预增超214%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605103044","media":"时代财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605103044?lang=zh_cn&edition=full","pubTime":"2026-01-21 18:26","pubTimestamp":1768991173,"startTime":"0","endTime":"0","summary":"1月20日晚，CRO公司昭衍新药（603127.SH，06127.HK）发布年度业绩预告称，公司预计2025年实现归属于上市公司股东的净利润约2.33亿元到3.49亿元，同比增加约214.0%到371.0%。对于净利润上涨的原因，昭衍新药在公告中指出，本报告期内，生物资产市场价格上涨叠加自身自然生长增值，双重因素驱动其公允价值正向变动，为公司业绩做出积极贡献。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601213626185160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603127","06127"],"gpt_icon":0},{"id":"2605120385","title":"徐慕浩2025年四季度表现，泰信蓝筹精选混合基金季度涨幅3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605120385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605120385?lang=zh_cn&edition=full","pubTime":"2026-01-21 13:08","pubTimestamp":1768972088,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2025年四季度末，基金经理徐慕浩旗下共管理2只基金，本季度表现最佳的为泰信蓝筹精选混合，季度净值涨3.31%。徐慕浩在担任泰信竞争优选混合基金经理的任职期间累计任职回报184.47%，平均年化收益率为17.64%。持有期间的估算收益率为97.47%，持有期间东方盛虹在2020年到2021年的年报归属净利润增幅达496.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100018769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2605140561","title":"港股早知道 | 赤峰黄金预计2025年净利润同比增约70%-81%！创维集团拟私有化退市并分拆光伏业务上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2605140561","media":"智通财经","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605140561?lang=zh_cn&edition=full","pubTime":"2026-01-21 07:44","pubTimestamp":1768952696,"startTime":"0","endTime":"0","summary":"国家医保局：为“远程手术”等辅助操作统一价格立项国家医保局20日印发《手术与治疗辅助操作类医疗服务价格项目立项指南》，围绕3D打印、机械臂与远程手术等医疗科技创新成果，进行统一价格立项，引导“传统治疗”向“精准医疗”转型。一是用电负荷屡创新高。1月4日，全国最大电力负荷达到13.51亿千瓦，首创冬季负荷历史新高。公司已向联交所申请批准股份于2026年1月21日上午9时正起恢复在联交所买卖。","market":"sh","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395356.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06127","BK1198","02252","03931","BK1617","02675","BK1144","02800","BK1544","BK1610","06693","BK1141","BK1576","BK1100"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0522},{"period":"1month","weight":0.1806},{"period":"3month","weight":0.1343},{"period":"6month","weight":0.0483},{"period":"1year","weight":1.8836},{"period":"ytd","weight":0.1806}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.052832},{"month":2,"riseRate":0.75,"avgChangeRate":0.137943},{"month":3,"riseRate":0.4,"avgChangeRate":-0.007614},{"month":4,"riseRate":0.2,"avgChangeRate":-0.110118},{"month":5,"riseRate":0.8,"avgChangeRate":0.111301},{"month":6,"riseRate":0.6,"avgChangeRate":0.067356},{"month":7,"riseRate":0.8,"avgChangeRate":0.10434},{"month":8,"riseRate":0,"avgChangeRate":-0.152531},{"month":9,"riseRate":0.6,"avgChangeRate":0.016217},{"month":10,"riseRate":0.2,"avgChangeRate":-0.062992},{"month":11,"riseRate":0.4,"avgChangeRate":0.019594},{"month":12,"riseRate":0.6,"avgChangeRate":0.001916}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}